A Phase I/II study of systemic chemotherapy with Docetaxel, Oxaliplatin, and S-1 followed by surgery in locally advanced adenocarcinoma of the esophagogostric junctio
Phase 1
Recruiting
- Conditions
- locally advanced adenocarcinoma of the esophagogastric junction
- Registration Number
- JPRN-UMIN000022210
- Lead Sponsor
- Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Concurrent cancers 2) Pregnant or breast-feeding female. Male or female who wants to have children 3) Psychiatric disorders or severe psychiatric symptoms 4) Continuous use of systemic steroid 5) Positive for HBs antigen 6) Continuous use of flucytosine or phenytoin or warfarin 7) Severe drug allergy 8) Infectious disease or suspicion of infectious disease 9) Acute myocardial infarction within 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method